Mylan to infuse USD 1 billion on capex in India Medical Dialogues Bureau30 Sep 2019 4:00 AM GMTMylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million towards...
Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan Medical Dialogues Bureau19 Jun 2019 6:31 AM GMTOnline pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan, ...
Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN Farhat Nasim1 April 2019 4:20 AM GMTAurobindo Pharma is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations.New Delhi:...
